Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Missale

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infectionR Nayersina, P Fowler, S Guilhot, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine developmentV Lamonaca, G Missale, S Urbani, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Hepatology (Baltimore, Md.)|July 27, 1999
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variationM U Mondelli, A Cerino, A Lisa, et al.
The Pharmacogenomics Journal|January 9, 2013
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapyF V Negri, A Musolino, N Naldi, et al.
Journal of Viral Hepatitis|January 11, 2007
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infectionJ Westin, M Lagging, A P Dhillon, et al.
British Journal of Cancer|July 30, 2014
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenograftsM Chiu, S Tardito, S Pillozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2020
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patientsG Mazzaschi, R Minari, A Zecca, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2016
Years of life that could be saved from prevention of hepatocellular carcinomaA Cucchetti, F Trevisani, L Bucci, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2015
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomeL Bucci, F Garuti, V Camelli, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infectionR Nayersina, P Fowler, S Guilhot, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine developmentV Lamonaca, G Missale, S Urbani, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Hepatology (Baltimore, Md.)|July 27, 1999
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variationM U Mondelli, A Cerino, A Lisa, et al.
The Pharmacogenomics Journal|January 9, 2013
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapyF V Negri, A Musolino, N Naldi, et al.
Journal of Viral Hepatitis|January 11, 2007
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infectionJ Westin, M Lagging, A P Dhillon, et al.
British Journal of Cancer|July 30, 2014
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenograftsM Chiu, S Tardito, S Pillozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2020
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patientsG Mazzaschi, R Minari, A Zecca, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2016
Years of life that could be saved from prevention of hepatocellular carcinomaA Cucchetti, F Trevisani, L Bucci, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2015
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomeL Bucci, F Garuti, V Camelli, et al.
Pageof 8